BL
Bausch + Lomb
BLCO·NYSELaval CAFounded 185313,000 employees
Mid CappharmaPublicOphthalmology
Platform: Eye Health
Market Cap
$4B
All Drugs
3
Clinical Trials
7
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (BLCO)
Loading BLCO stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Fixatuximab | BLC-126 | Phase 1/2 | 2 | Cl18.2 | AML | ||
| BLC-3714 | BLC-3714 | Approved | 4 | CD38 | RSVSCD | ||
| BLC-6641 | BLC-6641 | Phase 3 | 1 | AuroraA | NASHCSU |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (8)